In one study that evaluated the immunohistochemical analysis of PRLr protein expression levels via a tissue microarray of 102 cases, PRLr expression was found to be significantly downregulated in invasive breast cancer and was associated with lymph node negativity and low-grade well-differentiated tumors [24]. Here, PRLR is linked to invasive breast carcinoma.